News releases from the National Institutes of Health (NIH)
Updated: 8 hours 24 min ago
Novel research in mice sheds light on hormone regulation needed in late pregnancy, opens door for therapy.
“Phage” therapies offer potential strategy to combat antibacterial resistance.
By eliminating extraneous light, the scientists improved resolution by 33%.
Researchers hope the new approach will be used as a framework for publishing studies on polygenic risk scores.
Protein AEG12 strongly inhibits the family of viruses that cause yellow fever, dengue, West Nile, and Zika.
NIH, NIAID, scientists, human, cerebral organoid, test, drug, Creutzfeldt-Jakob disease.
Trial explores the use of the Eliquis® in patients who have been discharged from the hospital following a diagnosis of moderate-to-severe COVID-19.
ACTIV-3 is a master protocol designed to allow for the study of multiple investigational agents compared to placebo in adults hospitalized with COVID-19.
Finding could lead to new ways to reduce complications from painful red blood cell disorder.
Effort is part of the Accelerating Medicines Partnership to enable development of effective targeted therapies.
Study shows the treatment is safe, but provides no significant benefit in this group.
Findings suggest that the pandemic may have impacted the availability and demand of some, but not all, illegal drugs.
Program to investigate why some children are at greater risk for SARS-CoV-2 infection than others.
Newly authorized COVID-19 diagnostic kit is paired with smartphone app.
The single-shot vaccine is the third COVID-19 vaccine in the United States to be granted an EUA.
NIH-supported findings also show cardiovascular risks and pregnancy complications can raise chances of hypertension years after childbirth .
NIH-funded study shows how novelty triggers neural mechanisms that facilitate flexible strategy encoding
Results may explain why reinfection appears to be relatively rare.
Antibodies were well tolerated and generally safe when administered simultaneously to healthy adults.
Using viruses instead of antibiotics to tame troublesome drug-resistant bacteria is a promising strategy.